125 related articles for article (PubMed ID: 11129544)
21. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
22. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
[TBL] [Abstract][Full Text] [Related]
23. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
[TBL] [Abstract][Full Text] [Related]
25. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
26. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
[TBL] [Abstract][Full Text] [Related]
29. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.
Robertson J; Meier M; Wall J; Ying J; Fichtenbaum CJ
Clin Infect Dis; 2006 Jun; 42(11):1639-46. PubMed ID: 16652323
[TBL] [Abstract][Full Text] [Related]
30. [Acceptance of, compliance with and tolerance to antiretroviral treatment in patients with human immunodeficiency virus infection].
Knobel H; Serrano C; Hernández P; Pavesi M; Díez A
An Med Interna; 1997 Sep; 14(9):445-9. PubMed ID: 9453751
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience].
Alp E; Bozkurt I; Doğanay M
Mikrobiyol Bul; 2011 Jan; 45(1):125-36. PubMed ID: 21341167
[TBL] [Abstract][Full Text] [Related]
32. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy.
Masannat FY; Ampel NM
Clin Infect Dis; 2010 Jan; 50(1):1-7. PubMed ID: 19995218
[TBL] [Abstract][Full Text] [Related]
33. [Failure of first-line antiretroviral therapy in HIV-infected children in Ouagadougou, Burkina Faso].
Kouéta F; Yé D; Zoungrana A; Sacko A; Ouédraogo-Traoré R; Kafando E; Ouédraogo S
Med Trop (Mars); 2010 Dec; 70(5-6):517-23. PubMed ID: 21520658
[TBL] [Abstract][Full Text] [Related]
34. Family nutritional support improves survival, immune restoration and adherence in HIV patients receiving ART in developing country.
Serrano C; Laporte R; Ide M; Nouhou Y; de Truchis P; Rouveix E; Adamou A; Pauly V; Mattei JF; Gastaut JA
Asia Pac J Clin Nutr; 2010; 19(1):68-75. PubMed ID: 20199989
[TBL] [Abstract][Full Text] [Related]
35. Managing HIV-infected patients on antiretroviral therapy in Rio de Janeiro, Brazil: do providers follow national guidelines?
Loo VS; Diaz T; Gadelha AM; Campos DP; Pilloto JH; Brandao PS; Grinsztejin B; Veloso dos Santos VG
AIDS Care; 2004 Oct; 16(7):834-40. PubMed ID: 15385238
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors for home deaths due to pneumonia among low socioeconomic level Chilean children, Santiago de Chile (1994)].
Véjar L; Casterán JC; Navarrete P; Sánchez S; LeCerf P; Castillo C
Rev Med Chil; 2000 Jun; 128(6):627-32. PubMed ID: 11016062
[TBL] [Abstract][Full Text] [Related]
37. [Invasive pulmonary aspergillosis in AIDS].
Darras-Joly C; Lucet JC; Laissy JP; Chochillon C; Casalino E; Joly V; Matheron S; Bouvet E
Pathol Biol (Paris); 1998 Jun; 46(6):416-7. PubMed ID: 9769872
[TBL] [Abstract][Full Text] [Related]
38. Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand.
Kitajima T; Kobayashi Y; Chaipah W; Sato H; Toyokawa S; Chadbunchachai W; Thuennadee R
AIDS Care; 2005 Apr; 17(3):359-66. PubMed ID: 15832884
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the consistency of refills for antiretroviral medications in two hospitals in the state of Rio de Janeiro, Brazil.
Seguy N; Diaz T; Campos DP; Veloso VG; Grinsztejin B; Teixeira L; Pillotto JH
AIDS Care; 2007 May; 19(5):617-25. PubMed ID: 17505922
[TBL] [Abstract][Full Text] [Related]
40. The impact of new antiretroviral regimes on HIV-associated hospital admissions and deaths.
Domingo P; Guardiola JM; Ris J; Nolla J
AIDS; 1998 Mar; 12(5):529-30. PubMed ID: 9543452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
